These results from multivariable proportional hazards modeling were robust with regard to adjustment for relevant clinical and blood biomarkers including gender, age, past CVD event, diabetes, apoB, statin use, anti-hypertensive use, smoking, ethanol use, and eGFR. This evidence concerns the gene APOB and diabetes mellitus.